Literature DB >> 8467812

Structure-function analysis of human IL-6 receptor: dissociation of amino acid residues required for IL-6-binding and for IL-6 signal transduction through gp130.

H Yawata1, K Yasukawa, S Natsuka, M Murakami, K Yamasaki, M Hibi, T Taga, T Kishimoto.   

Abstract

Here, we report the analysis of the structure-function relationship of the extracellular region of human interleukin 6 receptor (IL-6R). Upon binding of IL-6, IL-6R becomes associated extracellularly with a non-IL-6-binding but signal transducing molecule, gp130, and the IL-6 signal is generated. In this region, the cytokine receptor family domain, but not the immunoglobulin-like domain, was responsible both for IL-6 binding and for signal transduction through gp130. Because a soluble, extracellular portion of IL-6R (sIL-6R) could bind IL-6 and mediate IL-6 functions through gp130, amino acid substitutions were introduced into sIL-6R by site-directed mutagenesis. The results, together with the previously proposed tertiary structure model, suggested that the amino acid residues critical for IL-6 binding have a tendency to be distributed to the hinge region between the two 'barrel'-like fibronectin type III modules and to the same side of these two 'barrels'. Amino acid residues, of which substitutions barely affected the IL-6-binding but did abolish the IL-6 signalling capability of sIL-6R, were identified and found to be located mainly in the membrane proximal half of the second barrel. sIL-6R mutants carrying such substitutions lacked the capacity to associate with gp130 in the presence of IL-6.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8467812      PMCID: PMC413384          DOI: 10.1002/j.1460-2075.1993.tb05815.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  24 in total

1.  Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies.

Authors:  Y Hirata; T Taga; M Hibi; N Nakano; T Hirano; T Kishimoto
Journal:  J Immunol       Date:  1989-11-01       Impact factor: 5.422

2.  Truncation of the c-myb gene by a retroviral integration in an interleukin 3-dependent myeloid leukemia cell line.

Authors:  Y Weinstein; J N Ihle; S Lavu; E P Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

3.  Crystal structure of chaperone protein PapD reveals an immunoglobulin fold.

Authors:  A Holmgren; C I Bränden
Journal:  Nature       Date:  1989-11-16       Impact factor: 49.962

Review 4.  The biology of interleukin-6.

Authors:  T Kishimoto
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

5.  Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130.

Authors:  T Taga; M Hibi; Y Hirata; K Yamasaki; K Yasukawa; T Matsuda; T Hirano; T Kishimoto
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

6.  Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor.

Authors:  W C Fanslow; J E Sims; H Sassenfeld; P J Morrissey; S Gillis; S K Dower; M B Widmer
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

7.  The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms.

Authors:  B Mosley; M P Beckmann; C J March; R L Idzerda; S D Gimpel; T VandenBos; D Friend; A Alpert; D Anderson; J Jackson
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

8.  Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor.

Authors:  K Yamasaki; T Taga; Y Hirata; H Yawata; Y Kawanishi; B Seed; T Taniguchi; T Hirano; T Kishimoto
Journal:  Science       Date:  1988-08-12       Impact factor: 47.728

9.  Recombinant human interleukin 6 (B-cell stimulatory factor 2) is a potent inducer of differentiation of mouse myeloid leukemia cells (M1).

Authors:  C Miyaura; K Onozaki; Y Akiyama; T Taniyama; T Hirano; T Kishimoto; T Suda
Journal:  FEBS Lett       Date:  1988-07-04       Impact factor: 4.124

10.  Identification of three adjacent amino acids of interleukin-2 receptor beta chain which control the affinity and the specificity of the interaction with interleukin-2.

Authors:  J L Imler; A Miyajima; G Zurawski
Journal:  EMBO J       Date:  1992-06       Impact factor: 11.598

View more
  50 in total

Review 1.  Receptor recognition by gp130 cytokines.

Authors:  J Bravo; J K Heath
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  Structure of the extracellular domains of the human interleukin-6 receptor alpha -chain.

Authors:  J N Varghese; R L Moritz; M-Z Lou; A Van Donkelaar; H Ji; N Ivancic; K M Branson; N E Hall; R J Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

Review 3.  Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury.

Authors:  J Gordon Boyd; Tessa Gordon
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

4.  Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer.

Authors:  A Kamiya; T Kinoshita; Y Ito; T Matsui; Y Morikawa; E Senba; K Nakashima; T Taga; K Yoshida; T Kishimoto; A Miyajima
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

5.  Maternal IL-11Ralpha function is required for normal decidua and fetoplacental development in mice.

Authors:  P Bilinski; D Roopenian; A Gossler
Journal:  Genes Dev       Date:  1998-07-15       Impact factor: 11.361

6.  Crystal structure of a cytokine-binding region of gp130.

Authors:  J Bravo; D Staunton; J K Heath; E Y Jones
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

Review 7.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

8.  Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis.

Authors:  F De Benedetti; M Massa; P Pignatti; S Albani; D Novick; A Martini
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

9.  Constitutive activation of a variant of the env-mpl oncogene product by disulfide-linked homodimerization.

Authors:  G Courtois; L Bénit; Y Mikaeloff; M Pauchard; M Charon; P Varlet; S Gisselbrecht
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

10.  Human interleukin-3 (IL-3) induces disulfide-linked IL-3 receptor alpha- and beta-chain heterodimerization, which is required for receptor activation but not high-affinity binding.

Authors:  F C Stomski; Q Sun; C J Bagley; J Woodcock; G Goodall; R K Andrews; M C Berndt; A F Lopez
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.